AVAC: Global Advocacy for HIV Prevention was founded in December 1995 to advocate for the development of a safe, effective, and accessible HIV vaccine. It seeks to promote increased funding and investment in HIV vaccine research by government agencies, private industry and non-governmental organizations; to identify barriers to the development of a vaccine; and to increase public awareness about the need for a well funded, coordinated HIV vaccine research program. It seeks to promote increased HIV vaccine advocacy efforts by community-based organizations and increased awareness about HIV vaccine development among AIDS-affected communities. It is committed to the principle that funds for HIV vaccine research are not to be taken from basic HIV research, drug development or prevention efforts.
Categories Covered:HIV Treatment and Medical Care, Tools and Tips for HIV Advocacy, Women, HIV Stigma and Discrimination, PrEP (HIV Pre-Exposure Prophylaxis), HIV Advocacy and Activism, HIV in Specific Countries, HIV Prevention and Transmission, HIV Prevention Methods, HIV Testing, HIV Epidemiology, HIV Policy and Advocacy, HIV Treatments in Development, HIV Treatment Strategies, Vaccines and Microbicides for HIV, Regional/Global Anti-HIV Efforts, Gay Men, PrEP (HIV Pre-Exposure Prophylaxis), HIV-Related Policy Issues, HIV in the Trump Era, African-Americans, HIV Care Continuum, Providing Quality HIV Care, HIV Care and Services Outside the US, Tenofovir Disoproxil Fumarate (Viread), Other Populations, Adverse Events, Comorbidities, and HIV, Trans People, Curing HIV
"As this HIVR4P conference enters its final day," AVAC writes, "we feel like it's safe to say that this conference heralded an energized, nuanced commitment to choice."
A new report issued at this year's HIVR4P conference states that flat and/or reduced funding for HIV/AIDS and other global health issues threatens to roll back progress worldwide.
While there are modeling studies that look at lives saved versus lost because of these contraception methods, advocates are calling far and wide for better choices.
Eight young African women interested in HIV prevention research submitted a letter to the National Institutes of Health's Division of AIDS listing what they consider should be HIV prevention research priorities for the next several years.